about
Biomarkers of intestinal fibrosis - one step towards clinical trials for stricturing inflammatory bowel diseaseCoeliac diseaseThe function of tissue transglutaminase in celiac diseaseIncreased expression of mucosal addressin cell adhesion molecule 1 in the duodenum of patients with active celiac disease is associated with depletion of integrin alpha4beta7-positive T cells in bloodPrevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment.Post-splenectomy and hyposplenic states.Small Amounts of Gluten in Subjects With Suspected Nonceliac Gluten Sensitivity: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial.Altered expression of type-1 and type-2 cannabinoid receptors in celiac diseaseDefective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's diseaseEpithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease.A gut-vascular barrier controls the systemic dissemination of bacteria.Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin.Impact of patient characteristics on the clinical efficacy of mongersen (GED-0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease.Abnormal thymic stromal lymphopoietin expression in the duodenal mucosa of patients with coeliac disease.Dendritic cells in intestinal homeostasis and disease.Recent advances in understanding Crohn's disease.Recent advances in understanding ulcerative colitis.Proteases and the gut barrier.Is it worth investigating splenic function in patients with celiac disease?Innate and adaptive immunity in inflammatory bowel disease.The role of transforming growth factor (TGF)-β in modulating the immune response and fibrogenesis in the gut.New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract.Vaccination coverage and mortality after splenectomy: results from an Italian single-centre study.CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide.European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's Disease.Plasma citrulline as a quantitative biomarker of HIV-associated villous atrophy in a tropical enteropathy population.Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases.Epstein-Barr virus-positive ileal carcinomas associated with Crohn's disease.How I treat enteropathy-associated T-cell lymphoma.Low Serum Levels of MicroRNA-19 Are Associated with a Stricturing Crohn's Disease Phenotype.Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease.In Crohn's disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts.Absence of a role for interleukin-13 in inflammatory bowel disease.Effect of tumor necrosis factor-α blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease.CC-10004 but not thalidomide or lenalidomide inhibits lamina propria mononuclear cell TNF-α and MMP-3 production in patients with inflammatory bowel disease.Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease.Abnormal anandamide metabolism in celiac disease.Splenic hypofunction and the spectrum of autoimmune and malignant complications in celiac disease.The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: tailoring better vaccination strategies.
P50
Q26740542-DFE11339-0A16-46EE-89BB-11A26F13E25FQ28242747-824905B5-205C-4F9F-BCA6-F00C2E3C90B9Q28259501-6E7EB923-5D22-477C-989B-BADBD1663575Q28307258-D745F5AB-C1FF-4E86-8261-2E10904E6E20Q33632204-AE6790DD-8AE2-47CE-9A14-92F1CE462691Q34176573-B6860A17-0B10-4C91-BF9B-F48627F186B1Q34463897-98E4BEF8-74CA-429A-839B-BF1CD4F7D9D9Q34689405-384301A1-3355-41B3-93B9-2431828FF7A6Q35596219-CA54B35F-8CE9-4751-B319-C0CA410D7A08Q35760432-0131F307-F74C-467C-823A-D91202AC78AEQ35840463-13DC8841-66DD-497B-9152-325A078C9B5EQ35947790-CC546355-40A6-4C28-ACD7-9FC9BD634E03Q36847655-BFB303BE-D1FE-41B5-956B-CDDB9026A8FFQ37282566-357D29A4-3A96-40C8-9C9B-0C8F1E40720DQ37591719-3E7E4F13-C526-4E59-8C70-39FA5FF26BAFQ37873392-0642C262-CF91-4AE2-BA1C-4948FB8BD650Q37954101-A44FA4F1-2DEE-44AF-8130-8955B4695D93Q37994635-767E1683-E1CB-4152-9BB1-C0A2F913525BQ38101325-513A6AD9-B250-4FCE-AF5A-7D6F6E350C75Q38115075-CA6A2DF0-9160-4301-8A64-274742F636FBQ38170837-A31CC32B-66CA-48CE-9802-37AE151C5450Q38566990-7B0044CF-1B4D-42D8-873C-077EE457E74FQ38644008-0F5E12C7-7A4A-43A7-82EF-A06AE5AFB7CAQ38705684-1B51C9FD-AA9B-4B51-81D6-2692B7347339Q38755907-69675066-D4AD-43A1-B1DF-4AFD68AA365FQ39337332-F85241ED-75FC-46D0-AEAD-6D1A4C2C55C6Q39451272-A1D90E80-D7A7-4959-8731-A134404C2509Q40104628-519C3839-B2A3-48C0-9B50-75E291160576Q40298485-1B240CA5-B316-4B03-905C-E52ECC3FA537Q40928156-E19BF7E0-9B01-4923-BB68-8712AF5EA708Q41839820-BE0447DB-61F0-46AD-A1A4-26215634EA36Q42223480-A888FBCB-B762-4E13-A850-A0DEADB33E30Q42236791-93E00CCB-7E93-4825-B7A2-62181B1C0F81Q42278326-D0A5818A-D172-4F73-9BB4-FF46B5178456Q42775179-DBC05C5A-546C-4E7D-8874-AF75AD9863A5Q42929133-594F77EC-5485-4EAE-840E-A25A2EC8C895Q43769821-9F56599C-8525-4731-9BE5-09F29A591187Q44260279-A5303902-BF93-409B-AE44-2DED40587C6BQ44797573-75EE9341-826A-472E-B498-F419B683F671Q44900118-12406328-F1A6-4A1A-B270-F9B6E63E359E
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Antonio Di Sabatino
@ast
Antonio Di Sabatino
@en
Antonio Di Sabatino
@es
Antonio Di Sabatino
@nl
type
label
Antonio Di Sabatino
@ast
Antonio Di Sabatino
@en
Antonio Di Sabatino
@es
Antonio Di Sabatino
@nl
prefLabel
Antonio Di Sabatino
@ast
Antonio Di Sabatino
@en
Antonio Di Sabatino
@es
Antonio Di Sabatino
@nl
P214
P1053
K-8015-2016
P106
P1153
6603698114
P21
P214
P31
P3829
P496
0000-0002-0302-8645
P735
P7859
viaf-310597453